Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

691
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
691
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversible Control of Ferrimagnetic Skyrmion Generation and Motion via Hydrogen Migration Under Electric Field.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Association of GLP-1RA discontinuation and risk of depressive and anxiety disorders in people with type 2 diabetes: a cohort study.

Nature metabolism·2026
Same author

Optical coherence tomography-derived macrophage arc as a novel biomarker for predicting adverse cardiovascular events in coronary artery disease: a multicentre study.

European heart journal. Imaging methods and practice·2026
Same author

Low-substrate nitrogen drives functional succession toward a cooperative Candidatus Brocadia consortium in anammox systems.

Bioresource technology·2026
Same author

SAS-bench: A fine-grained benchmark for evaluating short answer scoring with large language models.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Integrated metagenomics unravels the microbial mechanisms driving greenhouse gas and odor emissions during composting.

Bioresource technology·2026

Related Experiment Video

Updated: Dec 25, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K

Application of Generalized Split Linearized Bregman Iteration algorithm for Alzheimer's disease prediction.

Weimin Zheng1, Bin Cui1, Zeyu Sun2

  • 1Department of Radiology, Aerospace Center Hospital, Beijing 100049, China.

Aging
|April 6, 2020
PubMed
Summary

This study introduces a new machine learning method, Generalized Split Linearized Bregman Iteration (GSplit LBI), for detecting Alzheimer's disease (AD) using brain MRI scans, achieving high accuracy.

Keywords:
Alzheimer's diseasefeature selectiongeneralized split linearized Bregman iterationmachine learningvoxel-based structural magnetic resonance imaging

More Related Videos

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.5K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.3K

Related Experiment Videos

Last Updated: Dec 25, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.6K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.5K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.3K

Area of Science:

  • Neuroimaging
  • Machine Learning
  • Medical Diagnostics

Background:

  • Alzheimer's disease (AD) diagnosis relies on clinical assessments and neuroimaging.
  • Accurate and early detection of AD is crucial for effective patient management.
  • Structural magnetic resonance imaging (sMRI) provides valuable data for AD detection.

Purpose of the Study:

  • To develop and validate a novel machine learning algorithm for Alzheimer's disease detection using sMRI data.
  • To assess the accuracy and generalization capability of the proposed classification method.
  • To identify key brain regions predictive of Alzheimer's disease.

Main Methods:

  • Application of a novel machine learning algorithm, Generalized Split Linearized Bregman Iteration (GSplit LBI), combining logistic regression and structural sparsity.
  • Utilized a dataset of 57 Alzheimer's disease patients and 47 normal controls, extracting gray matter volume.
  • Employed 10-fold cross-validation and cross-testing on independent datasets (ADNI, Chinese cohort) for validation.

Main Results:

  • The GSplit LBI model achieved a classification accuracy of 90.44% in the local cohort.
  • Identified top predictive voxels (6% of parameters) contributing to accurate AD classification.
  • Demonstrated good performance and stable feature selection across different cohorts, including ADNI.

Conclusions:

  • The developed GSplit LBI algorithm offers a highly accurate and reliable method for Alzheimer's disease detection from sMRI.
  • The algorithm exhibits strong generalization capabilities, performing well on diverse patient populations.
  • GSplit LBI shows potential for clinical application in early and accurate Alzheimer's disease diagnosis.